<p>Established Models use information from atherothrombotic markers, only (AT, only). New Models add information from inflammatory markers (CRP and IL-6) to the Established Model.</p><p><b>Abbreviations</b>: CAV: Cardiac Allograft Vasculopathy; CRP: C-reactive protein; IL-6: Interleukin-6; OR: Odds Ratio; C.I.: Confidence Interval; AT: Atherothrombotic; tPA: tissue plasminogen activator; MMF: Mycophenolate mofetil; HLA-AB: human leukocyte antigen-A, -B.</p><p>Logistic regression models for the prediction of CAV using all biopsies obtained within the first 3-months post-transplant.</p
Cardiac allograft vasculopathy (CAV) is the principal cause of long-term graft failure following hea...
Cardiac allograft vasculopathy (CAV) is a leading cause of morbidity and mortality for heart transpl...
Objective: To investigate the modifiable, non-immune risk factors associated with cardiac allograft ...
<p>Established Models use information from atherothrombotic markers, only (AT, only). New Models add...
<p>Median IL-6 and CRP values measured over the first 3 months post-transplant were used in all pred...
<p>Both models were developed using markers obtained from the 1<sup>st</sup> biopsy only (median 9-d...
<p>Established Models use information from atherothrombotic markers, only (AT, only). New Models add...
<p>Established Models use information from atherothrombotic markers, only (AT, only). New Models add...
<p>Abbreviations: OR: Odds Ratio; CI: 95% confidence interval for the OR; tPA: Tissue Plasminogen Ac...
<p>Abbreviations: OR: Odds Ratio; CI: 95% confidence interval for the OR; tPA: Tissue Plasminogen Ac...
<p>Abbreviations: OR: Odds Ratio; CI: 95% confidence interval for the OR; tPA: Tissue Plasminogen Ac...
BACKGROUND: Identification of risk is essential to prevent cardiac allograft vasculopathy (CAV) and ...
Identification of risk is essential to prevent cardiac allograft vasculopathy (CAV) and graft failur...
Background: Identification of risk is essential to prevent cardiac allograft vasculopathy (CAV) and ...
<p>Both models were developed using markers obtained from the 1<sup>st</sup> biopsy only (median 9-d...
Cardiac allograft vasculopathy (CAV) is the principal cause of long-term graft failure following hea...
Cardiac allograft vasculopathy (CAV) is a leading cause of morbidity and mortality for heart transpl...
Objective: To investigate the modifiable, non-immune risk factors associated with cardiac allograft ...
<p>Established Models use information from atherothrombotic markers, only (AT, only). New Models add...
<p>Median IL-6 and CRP values measured over the first 3 months post-transplant were used in all pred...
<p>Both models were developed using markers obtained from the 1<sup>st</sup> biopsy only (median 9-d...
<p>Established Models use information from atherothrombotic markers, only (AT, only). New Models add...
<p>Established Models use information from atherothrombotic markers, only (AT, only). New Models add...
<p>Abbreviations: OR: Odds Ratio; CI: 95% confidence interval for the OR; tPA: Tissue Plasminogen Ac...
<p>Abbreviations: OR: Odds Ratio; CI: 95% confidence interval for the OR; tPA: Tissue Plasminogen Ac...
<p>Abbreviations: OR: Odds Ratio; CI: 95% confidence interval for the OR; tPA: Tissue Plasminogen Ac...
BACKGROUND: Identification of risk is essential to prevent cardiac allograft vasculopathy (CAV) and ...
Identification of risk is essential to prevent cardiac allograft vasculopathy (CAV) and graft failur...
Background: Identification of risk is essential to prevent cardiac allograft vasculopathy (CAV) and ...
<p>Both models were developed using markers obtained from the 1<sup>st</sup> biopsy only (median 9-d...
Cardiac allograft vasculopathy (CAV) is the principal cause of long-term graft failure following hea...
Cardiac allograft vasculopathy (CAV) is a leading cause of morbidity and mortality for heart transpl...
Objective: To investigate the modifiable, non-immune risk factors associated with cardiac allograft ...